Inventor
MUJICA ALEXANDER O
US18 patents
Patents
18 patentsUS10385359B2Aug 20, 2019
Targeted modification of rat genome
REGENERON PHARMA29 citations94
US10390522B2Aug 27, 2019
Non-human animals having a humanized programmed cell death 1 gene
REGENERON PHARMA6 citations84
US10070631B2Sep 11, 2018
Rodents having a humanized TMPRSS gene
REGENERON PHARMA4 citations82
US10070632B2Sep 11, 2018
Rodents having a humanized TMPRSS gene
REGENERON PHARMA5 citations82
US10781453B2Sep 22, 2020
Non-human animals having a hexanucleotide repeat expansion in a C9ORF72 locus
REGENERON PHARMA6 citations79
US10975390B2Apr 13, 2021
Targeted modification of rat genome
REGENERON PHARMA4 citations73
US11589562B2Feb 28, 2023
Mouse model of DITRA disease and uses thereof
REGENERON PHARMA2 citations72
US11102961B2Aug 31, 2021
Non-human animals having a humanized lymphocyte-activation gene 3
REGENERON PHARMA1 citations72
US10306874B2Jun 4, 2019
Non-human animals having a humanized lymphocyte-activation gene 3
REGENERON PHARMA4 citations72
US12396444B2Aug 26, 2025
Mouse comprising a humanized TRKB locus
REGENERON PHARMA0 citations62
US12096754B2Sep 24, 2024
Non-human animals having a humanized lymphocyte-activation gene 3
REGENERON PHARMA0 citations62
US12037596B2Jul 16, 2024
Targeted modification of rat genome
REGENERON PHARMA0 citations62
US11684050B2Jun 27, 2023
Non-human animals having a humanized programmed cell death 1 gene
REGENERON PHARMA1 citations62
US11419318B2Aug 23, 2022
Genetically modified rat comprising a humanized TRKB locus
REGENERON PHARMA1 citations62
US11910787B2Feb 27, 2024
Rodents having a humanized TMPRSS gene
REGENERON PHARMA0 citations61
US12471579B2Nov 18, 2025
Mouse model of DITRA disease and uses thereof
REGENERON PHARMA0 citations58
US11696572B2Jul 11, 2023
Non-human animals comprising a humanized ASGR1 locus
REGENERON PHARMA0 citations50
US10863729B2Dec 15, 2020
Rodents having a humanized TMPRSS gene
REGENERON PHARMA0 citations50